
The importance of diversity in genomic datasets
We look at a recent prostate cancer study that highlights the importance of inclusivity in genomic studies

Filling the gaps: sequencing a chromosome
A human chromosome has been sequenced in its entirety for the first time, but why is this breakthrough important for the future of our reference genome?

Richter’s syndrome study published
A new study by GEP fellow Niamh Appleby has found potential pathways and targets for the treatment of Richter’s syndrome – an aggressive form of adult leukaemia

Genomics and the new Covid-19 variant
What do we know about the new strain of coronavirus sweeping across the UK? And how did genomics help us get there?

Key genomic technologies of 2020: treatments old and new
In the second part of our review of the year’s genomic highlights, we look at the breakthroughs that are helping patients with rare disease and cancer

Key genomic technologies of 2020: fighting Covid-19
In the first of two articles reflecting on this year, we look at how genomics became central to tackling an unprecedented global pandemic

First polygenic cause found for neonatal diabetes
A new study has found the first ever polygenic cause for diabetes in children younger than six months of age

Researchers find ‘hidden’ coronavirus gene
A newly discovered gene within the genome of the SARS-CoV-2 virus could offer clues about its origins and a possible target for treatment

‘New’ de novo variants linked to developmental disorders
How do gene variants affect our health? We look at a recent study that has newly identified 28 genes associated with developmental disorders

Genomics first: identifying inflammatory disease
Scientists have discovered a new rare and deadly inflammatory disease in men, but how did genomics lead them to it?

Keeping genes in mind: genomics and mental illness
UCL Genetics Institute honorary professor and psychiatrist David Curtis explains the challenge of understanding mental illnesses like schizophrenia, and how recent advances in genomics could have a real impact on clinical practice

Covid-19: what’s in the genes?
We take a look at the latest developments in our understanding of the role of the human genome when it comes to disease severity